|
Volumn 46, Issue 7, 1991, Pages 512-523
|
Phosphodiesterase inhibitors: New opportunities for the treatment of asthma
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1 (3 CHLOROANILINO) 4 PHENYLPHTHALAZINE;
4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE;
4,5 DIHYDRO 6 [4 (1H IMIDAZOL 1 YL)PHENYL] 5 METHYL 3(2H) PYRIDAZINONE;
5 (4 ACETAMIDOPHENYL) 2(1H) PYRAZINONE;
6 (4 ACETAMIDOPHENYL) 1,2,3,4,4A,10B HEXAHYDRO 8,9 DIMETHOXY 2 METHYLBENZO[C][1,6]NAPHTHYRIDINE;
ANAGRELIDE;
BENZAFENTRINE;
CILOSTAMIDE;
CYCLIC AMP;
CYCLIC GMP;
DENBUFYLLINE;
DIPYRIDAMOLE;
ENOXIMONE;
IMAZODAN;
MILRINONE;
NITRAQUAZONE;
PHOSPHODIESTERASE INHIBITOR;
ROLIPRAM;
SIGUAZODAN;
SKF 96231;
THEOPHYLLINE;
TIBENELAST;
UNCLASSIFIED DRUG;
VINPOCETINE;
ZAPRINAST;
ZARDAVERINE;
AIRWAY;
ASTHMA;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
SMOOTH MUSCLE;
|
EID: 0025868447
PISSN: 00406376
EISSN: None
Source Type: Journal
DOI: 10.1136/thx.46.7.512 Document Type: Review |
Times cited : (361)
|
References (0)
|